Table 2.

Cardiovascular Disease Event Risks After Starting Antiretroviral Therapy

Time Since ART Start	INSTI		Other ART		Adjusteda Risk Difference	Adjusteda Risk Ratio
	Unadjusted CVD Event Risk	Adjusteda CVD Event Risk	Unadjusted CVD Event Risk	Adjusteda CVD Event Risk
6 months	0.28%	0.08%	0.12%	0.16%	−0.08% (−0.20 to 0.19)	0.49 (0.11–3.35)
1 year	0.28%	0.17%	0.33%	0.34%	−0.17% (−0.37 to 0.19)	0.49 (0.20–1.86)
2 years	0.68%	0.38%	0.54%	0.75%	−0.37% (−0.72 to 0.09)	0.50 (0.28–1.17)
5 years	2.38%	1.32%	1.51%	1.93%	−0.61% (−1.54 to 0.22)	0.68 (0.37–1.14)
8 years	6.94%	2.64%	2.61%	3.34%	−0.71% (−2.16 to 0.94)	0.79 (0.49–1.34)

Abbreviations: ART, antiretroviral therapy; CVD, cardiovascular disease; INSTI, integrase strand transfer inhibitor.

Adjusted for confounding and informative censoring (refer to Methods for a detailed list of covariates).